Home › Funds › Citadel Advisors › PCVX
Citadel Advisors position in PCVX
VAXCYTE INC · Health Care
Latest position (Q2 2026)358.10K sh
Reported value held$20.82M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 58.73K | $1.49M | New |
| Q4 2021 | 95.05K | $2.26M | Add |
| Q1 2022 | 729.55K | $17.62M | Add |
| Q2 2022 | 1.19M | $25.83M | Add |
| Q3 2022 | 1.55M | $37.09M | Add |
| Q4 2022 | 1.02M | $48.82M | Reduce |
| Q1 2023 | 864.41K | $32.40M | Reduce |
| Q2 2023 | 24.30K | $1.21M | Reduce |
| Q3 2023 | 30.31K | $1.54M | Add |
| Q4 2023 | 9.00K | $565.20K | Reduce |
| Q1 2024 | 68.62K | $4.69M | Add |
| Q2 2024 | 51.60K | $3.90M | Reduce |
| Q3 2024 | 82.47K | $9.42M | Add |
| Q4 2024 | 203.28K | $16.64M | Add |
| Q1 2025 | 165.09K | $6.23M | Reduce |
| Q2 2025 | 1.21M | $39.19M | Add |
| Q3 2025 | 252.70K | $9.10M | Reduce |
| Q4 2025 | 398.77K | $18.40M | Add |
| Q1 2026 | 197.60K | $11.48M | Reduce |
| Q2 2026 | 358.10K | $20.82M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PCVX
- Fidelity Management & Research (FMR) 20.85M sh · $1.21B · Q2 2026
- Janus Henderson Group 16.58M sh · $960.23M · Q1 2026
- BlackRock Inc 12.07M sh · $701.52M · Q2 2026
- Vanguard Group 12.19M sh · $562.63M · Q4 2025
- Wellington Management Group 7.00M sh · $407.00M · Q2 2026
- Geode Capital Management 3.46M sh · $201.13M · Q2 2026
- D. E. Shaw & Co 1.90M sh · $110.56M · Q2 2026
- Maverick Capital 1.61M sh · $93.78M · Q2 2026
- Charles Schwab Investment Management 1.46M sh · $85.15M · Q2 2026
- Goldman Sachs Group 1.38M sh · $79.98M · Q2 2026
- Northern Trust Corp 1.28M sh · $74.42M · Q2 2026
- Norges Bank Investment Management 1.25M sh · $72.42M · Q2 2026